Our latest publication looks into creating a long acting injectable for the release of the HIV protease inhibitor Saquinavir. For this we formed a microconfetti acetalated dextran that could be loaded with up to 50% drug.
Our latest publication looks into creating a long acting injectable for the release of the HIV protease inhibitor Saquinavir. For this we formed a microconfetti acetalated dextran that could be loaded with up to 50% drug.
Comments are closed.